PharmaCyte Biotech Inc (PMCB) — Working Capital to Net Assets Ratio
PharmaCyte Biotech Inc (PMCB) has a Working Capital to Net Assets ratio of 104.6% as of April 2026. Working capital of $36.59 Million (current assets of $37.42 Million minus current liabilities of $826.42K) is measured against net assets of $34.98 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PharmaCyte Biotech Inc (PMCB) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
PharmaCyte Biotech Inc Working Capital to Net Assets (2004–2026)
This chart shows how PharmaCyte Biotech Inc's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2004 to 2026. As of April 2026, the ratio stands at 104.6%, reflecting working capital of $36.59 Million against net assets of $34.98 Million USD. For the complete balance sheet picture, see how large is PharmaCyte Biotech Inc's balance sheet.
Annual Working Capital to Net Assets for PharmaCyte Biotech Inc (2004–2026)
The table below presents the year-by-year Working Capital to Net Assets ratio for PharmaCyte Biotech Inc from 2004 to 2026, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check PMCB asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 104.6% | $36.59 Million | $34.98 Million | $37.42 Million | $826.42K | ▲ +67.1 pp |
| 2025 | 37.5% | $19.46 Million | $51.89 Million | $22.38 Million | $2.91 Million | ▼ -71.4 pp |
| 2024 | 108.9% | $43.02 Million | $39.51 Million | $50.44 Million | $7.42 Million | ▲ +15.9 pp |
| 2023 | 92.9% | $67.56 Million | $72.69 Million | $68.15 Million | $586.58K | ▼ -1.4 pp |
| 2022 | 94.3% | $84.79 Million | $89.92 Million | $85.49 Million | $704.37K | ▲ +71.1 pp |
| 2021 | 23.2% | $1.55 Million | $6.68 Million | $2.28 Million | $724.78K | ▲ +23.1 pp |
| 2020 | 0.1% | $6.25K | $5.09 Million | $1.04 Million | $1.03 Million | ▲ +1.9 pp |
| 2019 | -1.8% | $-89.45K | $5.04 Million | $653.40K | $742.85K | ▼ -12.9 pp |
| 2018 | 11.1% | $639.70K | $5.77 Million | $1.28 Million | $644.17K | ▼ -25.5 pp |
| 2017 | 36.6% | $2.96 Million | $8.09 Million | $3.54 Million | $580.25K | ▲ +15.2 pp |
| 2016 | 21.4% | $1.39 Million | $6.52 Million | $2.03 Million | $637.64K | ▲ +7.8 pp |
| 2015 | 13.6% | $806.58K | $5.94 Million | $2.82 Million | $2.01 Million | ▼ -29.1 pp |
| 2014 | 42.6% | $3.81 Million | $8.94 Million | $4.19 Million | $373.67K | ▼ -169.0 pp |
| 2013 | 211.6% | $-1.95 Million | $-921.46K | $1.85 Million | $3.80 Million | ▲ +51.1 pp |
| 2012 | 160.5% | $-2.73 Million | $-1.70 Million | $1.06 Million | $3.79 Million | ▲ +40.2 pp |
| 2011 | 120.4% | $-3.28 Million | $-2.73 Million | $104.75K | $3.39 Million | ▼ -35.4 pp |
| 2010 | 155.8% | $-3.04 Million | $-1.95 Million | $13.68K | $3.05 Million | ▲ +147.7 pp |
| 2009 | 8.1% | $252.84K | $3.12 Million | $1.18 Million | $929.89K | ▼ -39.7 pp |
| 2008 | 47.8% | $3.55 Million | $7.44 Million | $3.74 Million | $180.56K | ▼ -29.5 pp |
| 2007 | 77.3% | $3.31 Million | $4.29 Million | $3.43 Million | $118.81K | ▲ +8.8 pp |
| 2006 | 68.5% | $3.02 Million | $4.41 Million | $3.13 Million | $106.21K | ▲ +62.0 pp |
| 2005 | 6.5% | $-84.77K | $-1.30 Million | $212.68K | $297.45K | ▲ +91.6 pp |
| 2004 | -85.0% | $130.45K | $-153.43K | $130.71K | $260.00 | — |